The Mumbai-based drug maker said the agreement strengthens the company's diabetes portfolio and accelerates its presence in the obesity segment.
Lupin Signs Licensing, Supply And Distribution Deal With Chinese Firm For Obesity Drug
Published 3 hours ago
Source: feeds.feedburner.com
Categories
Business
Related Articles from feeds.feedburner.com
22 minutes ago
"Will Knock The Hell Out ": Trump Threatens Iran Over Nuclear Enrichment
58 minutes ago
Trump Says US Hit Docking Area For Alleged Venezuela Drug Boats
1 hour ago
Trump Says He Was "Very Angry" Over Alleged Ukraine Attack On Putin Residence
1 hour ago
Karnataka To Rehouse Families Hit By Bengaluru Demolition Drive
1 hour ago
Keys Next Year? Delhi Moves to Repair Long-Abandoned Flats For Poor
1 hour ago